Plasma concentration of leptin, neuropeptide Y and tumor necrosis factor alpha in patients with cancers before and after radio- and chemotherapy;Stȩżenie leptyny, neuropeptydu Y oraz czynnika martwicy nowotworów alfa u chorych z nowotworami przed- i po radio- lub chemioterapii

Polskie Archiwum Medycyny Wewnetrznej

Volumn 106, Issue 2, 2001, Pages 657-668

  Kowalczuk, Anetta ^a   Wiȩcek, Andrzej ^a   Franek, Edward ^a   Kokot, Franciszek ^a  

^a Akademii Medyczncj we Wroclawiu

Author keywords

Leptin; Neuropeptide Y; Tumor necrosis factor alpha

Indexed keywords

LEPTIN; NEUROPEPTIDE Y; TUMOR NECROSIS FACTOR ALPHA;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BLOOD; BODY MASS; CACHEXIA; CASE CONTROL STUDY; FEMALE; HEAD AND NECK TUMOR; HUMAN; MALE; METABOLISM; MIDDLE AGED; NONHODGKIN LYMPHOMA;

ADULT; AGED; BODY MASS INDEX; CACHEXIA; CASE-CONTROL STUDIES; CHEMOTHERAPY, ADJUVANT; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LEPTIN; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NEUROPEPTIDE Y; RADIOTHERAPY, ADJUVANT; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035437008     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Gorzelińska L., Łuczak J.: Zespół wyniszczenia nowotworowego (kacheksja). Brak łaknienia (anoreksja). Nowa Medycyna 2000, 1, 1.
2. Sarraf P., Frederich R.C., Turner E.M. i wsp.: Multiple cytokines and acute inflammation raise mouse leptin levels: Potential role of inflammatory anorexia. J. Exp. Med., 1997, 185, 171.
3. Zumbach M.S., Boehme M.W.J., Wahl P. i wsp.: Tumor necrosis factor increases serum leptin levels in humans. J. Clin. Endocrinol. Metab., 1997, 82, 4080.
4. Zhang Y., Proenca R., Maffei M. i wsp.: Positional cloning of the mouse obese gene and its human homologue. Nature, 1994, 372, 425.
5. Wang O., Bing C., Al.-Barazanji K. i wsp.: Interactions between leptin and hypothalamic neuropeptide Y neurons in the control of food intake and energy homeostasis in rat. Diabetes, 1997, 46, 335.
6. Tan J.T., Patel B.K., Kaplan L.M. i wsp.: Regulation of leptin expression and secretion by corticosteroids and insulin. Implications for body weight. Endocrinology, 1998, 8, 85.
7. Grunberg S.M., Hesketh P.J.: Control of chemotherapy induced emesis. N. Engl. J. Med., 1993, 329, 1790
8. Spiessl B., Beahrs O.H., Hermanek P. i wsp.: Altas TNM. Ilustrowany przewodnik po klasyfikacji TNM/pTNM nowotworów złośliwych. Sanmedica, Wiedza i Życie, Warszawa, 1992.
9. Nakao T., Hino M., Yamane T. i wsp.: Expression of the leptin receptor in human leukaemic blast cells. Br. J. Haematol., 1998, 102, 740.
10. Mc Millan D.C., Simpson J.M., Preston T. i wsp.: Effect of megestrol acetate on weight loss, body composition and blond screen of gastrointestinal cancer patients. Clin. Nurt., 1994, 13, 85.
11. Morton N.M., Emilsson V., Leu Y.L. i wsp.: Leptin action in intestinal cells. J. Biol. Chem., 1998, 273, 26194.
12. Simons J.P., Schols A.M., Campfield L.A. i wsp.: Plasma concentration of total leptin and human Jung cancer associated cachexia. Clin. Sci. Colch., 1997, 3, 273.
13. Usuki K., Okazaki R., Iki S. i wsp.: Serum leptin levels during cancer chemotherapy. Ann. Hematol., 1998, 77, 191.
14. Wattanapenpaiboon N., Lukito W., Strauss B.J.G. i wsp.: Agreement of skinfold measurement and bioelectrical impedance analysis (BIA) methods with dual energy X-ray absorptiometry (DEXA) in estimating total body fat in Anglo-Celtic Australians. Int. J. Obes., 1998, 22, 854.
15. Hube F., Birgel M., Lee Y.M. i wsp.: Expression pattern of tumor necrosis factor receptors in subcutaneous and omental human adipose tissue: role of obesity and non-insulin-dependent diabetes mellitus. Eur. J. Clin. Invest., 1999, 29, 672.
16. Masuzaki H., Ogawa Y., Tsse N. i wsp.: Human obese gene expression. Adipocyte-specific expression and regional differences in the adipose tissue. Diabetes, 1995, 44, 855.
17. Dotsch J., Adelmann E., Englaro P. i wsp.: Relation of leptin and neuropeptide Y in human blood and cerebrospinal fluid. J. Neurol. Sc., 1997, 151, 185.
18. Niskanen L.K., Haffner S., Karhunen L.J. i wsp.: Serum leptin in obesity is related to gender and body fat topography but does not predict successful weight loss. Eur. J. Endocrinol., 1997, 137, 61.